Stock Evaluator: Autonomix Medical, Inc. (AMIX)
Autonomix Medical, Inc. AMIX
$3.25
-0.34
-9.47%
July 31, 2026 9:30:01 AM
EST
Volume: 71,072
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company’s technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Financial Summary
| Share Statistics | AMIX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2.0 | $334.8 | 1% |
|
| Shares Out (Mil) | 0.5 | 41.7 | 3% |
|
| Institutional Ownership | 57.6% | 77.3% | 38% |
|
| Float (Mil) | 0.5 | 34.7 | 1% |
|
| Beta | -1.41 | 0.86 | 1% |
|
| Avg Daily Volume (000s) | 9,172 | 266 | 96% |
|
| Price Change (52-week) |
(86.5%) | 60.7% | 5% |
|
| Growth | AMIX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | na | (5.8%) | na |
|
| EPS (5yr) | na | 10.7% | na |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | na | (16.1%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | AMIX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $152 | na |
|
| Net Income (TTM) (Mil) | ($17) | ($11) | 25% |
|
| EPS (TTM) | ($48.639) | ($0.500) | 1% |
|
| Operating Cash Flow (TTM) (Mil) | ($12) | ($2) | 18% |
|
| Net Cash Flow (TTM) (Mil) | na | $1 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $22 | 0% |
|
| Enterprise Value (Q1) (Mil) | ($4) | $304 | 2% |
|
| Valuation | AMIX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.33 | 2.88 | 5% |
|
| P/E | na | 30.5 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.9 | na |
|
| Ratios | AMIX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 59.1% | na |
|
| Net Margin | na | (7.7%) | na |
|
| ROA | (192.1%) | (13.7%) | 2% |
|
| ROE | (238.9%) | (15.9%) | 4% |
|
| Liabilities to Assets | 22.4% | 44.9% | 15% |
|
| F-Score | 1 | 4 | 1% |
|
Autonomix Medical, Inc. did not pass any screens on 7/30/2026.
